Your browser doesn't support javascript.
loading
The bromodomain inhibitor JQ1+ reduces calcium-sensing receptor activity in pituitary cell lines.
Lines, Kate E; Gluck, Anna K; Thongjuea, Supat; Bountra, Chas; Thakker, Rajesh V; Gorvin, Caroline M.
Afiliação
  • Lines KE; Academic Endocrine Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford,UK.
  • Gluck AK; Academic Endocrine Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford,UK.
  • Thongjuea S; Centre for Computational Biology, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Bountra C; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Thakker RV; Academic Endocrine Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford,UK.
  • Gorvin CM; Academic Endocrine Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford,UK.
J Mol Endocrinol ; 67(3): 83-94, 2021 07 26.
Article em En | MEDLINE | ID: mdl-34223822
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipófise / Azepinas / Triazóis / Receptores de Detecção de Cálcio Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipófise / Azepinas / Triazóis / Receptores de Detecção de Cálcio Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article